Comparative analysis of 99mTc-depreotide and 99mTc-EDDA/HYNIC-TOC thorax scintigrams acquired for the purpose of differential diagnosis of solitary pulmonary nodules

Nuclear Medicine Review

Volumn 9, Issue 1, 2006, Pages 24-29

  Płachcińska, Anna ^a   Mikołajczak, Renata ^b   Kozak, Józef ^c   Rzeszutek, Katarzyna ^d   Kuśmierek, Jacek ^a  

^a MEDICAL UNIVERSITY OF LODZ   (Poland)

^b SOLTAN INSTITUTE FOR NUCLEAR STUDIES   (Poland)

^c N Copernicus Hospital   (Poland)

^d Ctr for Treatm of Pulmon Diseases   (Poland)

Author keywords

Lung cancer; Octreotide; Receptor scintigraphy; Solitary pulmonary nodule; Somatostatin receptor

Indexed keywords

DEPREOTIDE TC 99M; ETHYLENEDIAMININEACETIC ACID TC 99M; HYDRAZINONICOTINAMIDO OCTREOTIDE[3 TYROSINE]; RADIOPHARMACEUTICAL AGENT; TEKTROTYD; TRACER; UNCLASSIFIED DRUG; DIAGNOSTIC AGENT; DRUG DERIVATIVE; EDDA; EDETIC ACID; OCTREOTIDE; SOMATOSTATIN; TECHNETIUM COMPLEX; TECHNETIUM TC 99M HYDRAZINONICOTINYL TYR(3) OCTREOTIDE; TECHNETIUM TC 99M HYDRAZINONICOTINYL-TYR(3)-OCTREOTIDE;

ADULT; AGED; ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC ERROR; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; DRUG ACCUMULATION; DRUG EFFICACY; FEMALE; HAMARTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMAGE QUALITY; LUNG ADENOCARCINOMA; LUNG INFILTRATE; LUNG NODULE; LUNG SCINTISCANNING; LYMPH NODE METASTASIS; MALE; MALIGNANT NEOPLASTIC DISEASE; MEDIASTINUM METASTASIS; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SQUAMOUS CELL CARCINOMA; STATISTICAL ANALYSIS; TISSUE DISTRIBUTION; TUBERCULOMA; COMPARATIVE STUDY; LUNG COIN LESION; METHODOLOGY; MIDDLE AGED; SCINTISCANNING; THORAX;

ADULT; AGED; COIN LESION, PULMONARY; DIAGNOSIS, DIFFERENTIAL; EDETIC ACID; FEMALE; HUMANS; MALE; MIDDLE AGED; OCTREOTIDE; ORGANOTECHNETIUM COMPOUNDS; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; SOMATOSTATIN; THORAX;

EID: 33745911584     PISSN: 15069680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. 99mTc Depreotide in the evaluation of solitary pulmonary nodules. Chest 2000; 117: 1232.
2. Kahn D, Menda Y, Kernstine K et al. The utility of 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer. Chest 2004; 125: 494-501.
3. 99mTc-depreotide SPECT. Respiration 2006. To be published.
4. Maecke HR, Béhé M. New octraotide derivatives labelled with technetium-99m [abstract]. J Nucl Med 1996; 37: 1144.
5. 99mTc-EDDA/ HYNIC TOC scintigraphy in differential diagnosis of solitary pulmonary nodules. Eur J Nucl Med Mol Imaging 2004; 31: 1005-1010.
6. 99mTc-EDDA//HYNIC TOC scintigraphy in differential diagnosis of solitary pulmonary nodules. Cancer Biother Radiopharm 2004; 19: 613-620.
7. 99mTc-EDDA/HYNIC-TOC scintigraphy in differentiation of solitary pulmonary nodules - a complementary role to visual analysis. Cancer Biother Radiopharm 2006; 21: 61-67.
8. 99mTc-EDDA/HYNIC-TOC scintigraphy - the effect of tumour size on optimal method of image assessment. Eur J Nucl Med Mol Imag 2006. Accepted for publication.
9. Freeman LM, Blaufox MD. Letter from the Editors. Semin Nucl Med 2002; 32: 77.
10. Goldsmith SJ. Guest Editorial. Semin Nucl Med 2002; 32: 78.
11. Reubi JC, Waser B, Schaer JC, Laissue JA. Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands. Eur J Nucl Med 2001; 28: 836-846.
12. Reubi JC, Waser B, Sheppard M, Macaulay V. Somatostatin receptors are present in small-cell but not in non-small-cell primary lung carcinomas: relationship to EGF-receptors. Int J Cancer 1990; 45: 269-274.
13. Bogden AE, Taylor JE, Moreau J-P, Coy DH, LePage DJ. Response of of human lung tumour xenografts to treatment with a somatostatin analogue (somatuline). Cancer Res 1990; 50: 4360-4365.
14. Krenning EP, Kwekkeboom DJ, Bakker WH et al. Somatostatin receptor scintigraphy with [111 In-DTPA-D-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients. Eur J Nucl Med 1993; 20: 716-731.
15. Kwekkeboom DJ, Kho GS, Lamberts SWJ, Reubi CJ, Laissue JA, Krenning EP. The value of octrotide scintigraphy in patients with lung cancer. Eur J Nucl Med 1994; 21: 1106-1113.
16. Fujita T, Yamaji Y, Sato M, Murao K, takahara J. Gene expression of somatostatin receptor subtypes, sst1 and sst2, in human lung cancer cell lines. Life Sci 1994; 55: 1797-1806.
17. Taylor JE, Theveniau MA, Bashirzadeh R, Reisine T, Eden PA. Detection of somatostatin receptor subtype 2 (sstr2) in established tumors and tumor cell lines: evidence for sstr2 heterogeneity. Peptides 1994; 15: 1229-1236.
18. Traub T, Petkov V, Ofluoglu S et al. 111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung. J Nucl Med 2001; 42: 1309-1315.
19. Papotti M, Croce S, Bello M et al. Expression of somatostatin receptor types 2, 3 and 5 in biopsies and surgical specimens of human lung tumours. Virchows Archiv 2001; 439: 787-797.
20. Kwekkeboom DJ, Krenning EP. Somatostatin receptor imaging. Sem Nucl Med 2002; 32: 84-91.
21. Reubi JC, Horisberger U, Laissue J. High density of somatostatin receptors in veins surrounding human cancer tissue: role in tumor-host interaction? Int J Cancer 1994; 56: 681-688.
22. Reubi JC, Schaer JC, Laissue JA Waser B. Somatostatin receptors and their subtypes in human tumors and in peritumoral vessels. Metabolism 1996; 45 (8 suppl 1): 39-41.
23. 99mTc-P829 in patients with Graves' disease. J Nucl Med 2003; 44: 1547-1555.
24. 99mTc-labelled radiopharmaceutical for imaging of somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111 In-labelled octreotide derivatives. Eur J Nucl Med. 2000; 27: 1318-1325.
25. Van den Bosche B, D'haeninck E, Bacher K et al. Biodistribution and dosimetry of 99mTc-depreotide (P829) in patients suffering from breast carcinoma. Cancer Biother Radiopharm 2004; 19: 776-783.
26. Baldwin DR, Eaton T, Kolbe J et al. Management of solitary pulmonary nodules: how do thoracic computed tomography and guided fine needle biopsy influence clinical decision? Thorax 2002; 57: 817-822.
27. 99mTc depreotide compared with F-18 fluorodeoxyglucose positron emission tomography and surgical staging in patients with suspected non-small cell lung cancer. Chest 2004; 125: 494-501.
28. 99mTc-depreotide in patients with lung cancer. Eur J Nucl Med Mol Imaging 2005; 32: 925-931.
29. 68Ga-DOTA-TOC PET and comparison to F-18-FDG. Eur J Nucl Med Mol Imaging 2006. To be published.